Accumulated evidence supports the constructive role of the CREB/BDNF pathway in enhancing memory and cognition, and disturbance of phosphorylated CREB/BDNF levels in the hippocampal region leading to the progression of neurodegenerative diseases such as Alzheimer’s and Parkinson’s [55,56]. This evidence concerns the gene CREB1 and Parkinson disease.